Literature DB >> 16897319

Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography.

Elissa M Strome1, Ivan L Cepeda, Vesna Sossi, Doris J Doudet.   

Abstract

PURPOSE: In the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease (PD), it is important to determine lesion severity. This evaluation can be performed in vivo, through evaluation of dopamine (DA)-dependent motor function or with small animal positron emission tomography (microPET), or at postmortem, by examining markers for DA neurons. PROCEDURES: Rats were given mild or severe unilateral 6-OHDA lesions, scanned with the tracer [(11)C](+/-)dihydrotetrabenazine ([(11)C]DTBZ), and tested on a tapered/ledged beam-walking task. At postmortem, autoradiography was performed with [(11)C]DTBZ.
RESULTS: Autoradiography was significantly correlated with microPET and behavioral scores, whereas the microPET and behavioral data were not significantly correlated.
CONCLUSIONS: This study shows that behavioral analysis, microPET, and autoradiography are all good tools for measuring the integrity of the DA system, and demonstrates the utility of the tapered/ledged beam-walking test to screen for lesion severity, as well as the importance of including postmortem analysis after in vivo imaging studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897319     DOI: 10.1007/s11307-006-0051-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  39 in total

1.  Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [11C]raclopride.

Authors:  Doris J Doudet; Salma Jivan; Thomas J Ruth; James E Holden
Journal:  Synapse       Date:  2002-06-01       Impact factor: 2.562

2.  MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging.

Authors:  Yuan-Chuan Tai; Arion F Chatziioannou; Yongfeng Yang; Robert W Silverman; Ken Meadors; Stefan Siegel; Danny F Newport; Jennifer R Stickel; Simon R Cherry
Journal:  Phys Med Biol       Date:  2003-06-07       Impact factor: 3.609

3.  The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.

Authors:  J M Wilson; S J Kish
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

4.  Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.

Authors:  J M Wilson; J N Nobrega; M E Carroll; H B Niznik; K Shannak; S T Lac; Z B Pristupa; L M Dixon; S J Kish
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

5.  Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats.

Authors:  K E Bowenkamp; L Ujhelyi; E J Cline; P C Bickford
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

6.  Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET.

Authors:  A H Moore; C L Osteen; A F Chatziioannou; D A Hovda; S R Cherry
Journal:  J Cereb Blood Flow Metab       Date:  2000-10       Impact factor: 6.200

7.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Authors:  T Vander Borght; M Kilbourn; T Desmond; D Kuhl; K Frey
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

8.  Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography.

Authors:  Akira Matsumura; Shigekazu Mizokawa; Masaaki Tanaka; Yasuhiro Wada; Satoshi Nozaki; Fusao Nakamura; Susumu Shiomi; Hironobu Ochi; Yasuyoshi Watanabe
Journal:  Neuroimage       Date:  2003-12       Impact factor: 6.556

9.  Quantitation in positron emission computed tomography: 5. Physical--anatomical effects.

Authors:  J C Mazziotta; M E Phelps; D Plummer; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1981-10       Impact factor: 1.826

10.  [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.

Authors:  Y Masuo; D Pélaprat; D Scherman; W Rostène
Journal:  Neurosci Lett       Date:  1990-06-22       Impact factor: 3.046

View more
  15 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

3.  An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ.

Authors:  Chao Zhao; Chunyi Liu; Jie Tang; Yingjiao Xu; Minhao Xie; Zhengping Chen
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

4.  Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study.

Authors:  Elena Prieto; María Collantes; Mercedes Delgado; Carlos Juri; Luis García-García; Francisco Molinet; María E Fernández-Valle; Miguel A Pozo; Belén Gago; Josep M Martí-Climent; José A Obeso; Iván Peñuelas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

5.  Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.

Authors:  Jeff Hewett; Peter Johanson; Nutan Sharma; David Standaert; Aygul Balcioglu
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

6.  Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats.

Authors:  Elissa M Strome; Athanasios P Zis; Doris J Doudet
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

7.  Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.

Authors:  Tina Kroll; David Elmenhorst; Andreas Matusch; Franziska Wedekind; Angela Weisshaupt; Simone Beer; Andreas Bauer
Journal:  Mol Imaging Biol       Date:  2013-03-01       Impact factor: 3.488

8.  Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.

Authors:  Yu Zhao; Michael DeCuypere; Mark S LeDoux
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

9.  Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.

Authors:  Cindy Casteels; Erwin Lauwers; Guy Bormans; Veerle Baekelandt; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

10.  PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models.

Authors:  Ronald L Klein; Robert D Dayton; Tracee L Terry; Chris Vascoe; John J Sunderland; Kerrie H Tainter
Journal:  Brain Res       Date:  2009-02-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.